MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Classifying pain in dystonia: a way to improve pain outcome measure in dystonia.

C. Listik, E. Listik, J. Lapa, G. Santos, F. Do Vale, R. Cury, M. Teixeira, J. Limongi, H. Ferraz, E. Barbosa, D. de Andrade (São Paulo, Brazil)

Meeting: MDS Virtual Congress 2021

Abstract Number: 123

Keywords: Dystonia: Clinical features, Pain

Category: Dystonia: Epidemiology, Genetics, Phenomenology

Objective: To improve the classification system for pain in dystonia.

Background: Pain is a frequent and incapacitating non-motor symptom in dystonia. Evidence indicates that pain in dystonia is not only of muscular origin, but pain’s descending modulatory systems are impaired in dystonia. There is much to be learned about this topic. Still, we do not have a simple and straightforward way to classify, evaluate pain, and assess its improvement after pharmacological, surgical, and non-invasive treatments.

Method: We evaluated 36 patients in a multicentric study with hereditary/idiopathic dystonia of any distribution. These results are preliminary finds of this multicentric assessment. We applied the Burke-Fahn-Marsden (BFM) dystonia scale, two pain scales (Douleur Neuropathique – DN4 and the short-form Brief Pain Inventory – BPI), and our developed classification system.

Results: Patients (54.9 ± 14.6 years, 41.7% male) had a BFM motor and disability subscores of 17.6 ± 6.8 and 4.5 ± 5.7, respectively, and 15 patients (41.7%) had chronic pain. Four patients had chronic pain non-related to dystonia, and 11 patients had chronic pain directly related to dystonia. Six patients had a second chronic pain, one of which was aggravated by dystonia, and five were directly associated with dystonia. DN4 was 2.1 ± 1.9, and BPI pain severity 5.2 ± 2.0 interference 5.0 ± 3.2.

Conclusion: Chronic pain is prevalent in dystonic patients and is frequently directly related to dystonia.

To cite this abstract in AMA style:

C. Listik, E. Listik, J. Lapa, G. Santos, F. Do Vale, R. Cury, M. Teixeira, J. Limongi, H. Ferraz, E. Barbosa, D. de Andrade. Classifying pain in dystonia: a way to improve pain outcome measure in dystonia. [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/classifying-pain-in-dystonia-a-way-to-improve-pain-outcome-measure-in-dystonia/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/classifying-pain-in-dystonia-a-way-to-improve-pain-outcome-measure-in-dystonia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley